IPMG communicates the role and contribution of R&D-based pharmaceutical manufacturers in helping people improve their quality of life as well as pushing for an advancement of an effective and integrated healthcare system in Indonesia.
- Representing the opinions and interests of IPMG members in discussions with the government, regulatory agencies, trade associations, professional associations, and local national pharmaceutical business.
- To promote and safeguard members’ interests in Indonesia by striving to influence policy developments affecting the health sector.
- To analyze and interpret the trends and the impacts of changes in legislation relating to the industry.
- To keep abreast of global developments in pharmaceutical policies through IPMG’s international representation as a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
To date, IPMG members have introduced more than 900 new products to treat cancer, infectious diseases, cardiovascular diseases and other illnesses in Indonesia.
Member companies employ more than 10,000 people in their operations